Findings showed that remibrutinib outperformed teriflunomide in the REMODEL-1 and REMODEL-2 phase 3 trials among adults with ...
In recognition of SMA Awareness Month, NeurologyLive® spoke with neuromuscular experts about how multidisciplinary care is ...
Diagnosing multiple sclerosis (MS) has changed considerably in recent years for neurologists in the field, with revised ...
Phase 1b/2 findings showed that the investigational anti-amyloid monoclonal antibody ABBV-916 produced dose-dependent ...
A phase 1 feasibility trial found that placing GammaTile radiation therapy directly into the surgical cavity during ...
Casey*, now in his 30s, recalls that period clearly. As a high school senior, Casey ate dinner after sports practice, went straight to bed, and spent up to 12 hours each night trying to sleep. Despite ...
The assistant professor of neurology at Mayo Clinic provided his thoughts on the next steps in understanding autoimmune encephalitis and the direction that research must pivot to.
The FDA was busy early this month, during the week of August 23, 2026, making a number of decisions on potential new ...
NeurologyLive Brain Games is a weekly, Sunday-morning quiz series featuring three questions authored by clinicians and ...
In honor of SMA Awareness Month, held annually throughout August, get caught up on the latest news in spinal muscular atrophy ...
The vice president of Neuroscience and Vaccines at Takeda discusses the clinical significance of oveporexton's FDA approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results